Loading
Latest filing published 18 Nov 2025 for Bioxytran, INC, €4,327. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alan M. Hoberman is a declared insider of Bioxytran, Inc (board member), with filings sourced from SEC (Form 4). Between 2 April 2021 and 12 August 2025, the trades on record add up to 13 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 18 November 2025 with a share grant (€4,327) in Bioxytran, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations